New drug combination regimen based on pharmacokinetic characteristics—Erdafitinib combined with sertraline or duloxetine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New drug combination regimen based on pharmacokinetic characteristics—Erdafitinib combined with sertraline or duloxetine

Published:2024-10 Issue: Volume:179 Page:117414
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Zhang Xiao-dan,Xu Xiao-yu,Zhong Yun-shan,Zhang Zhe-yan,Jin Le-hao,Luo Jian-chao,Ye Feng,Ni Jin-huan,Chen Jing,Chen Gao-zhi,Qian Jian-chang^ORCID,Liu Zhi-guo

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference39 articles.

1. FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions;Katoh;Nat. Rev. Clin. Oncol.,2024

2. B.L.C.S. Group, Erdafitinib in locally advanced or metastatic urothelial carcinoma;Loriot;N. Engl. J. Med,2019

3. Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4;Gattineni;Am. J. Physiol. Ren. Physiol.,2014

4. Multifunctional nanoparticle-mediated combining therapy for human diseases;Li;Signal Transduct. Target Ther.,2024

5. Drug combination in cancer treatment-from cocktails to conjugated combinations;Gilad;Cancers,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP